Precision BioSciences
DTIL
52 hedge funds and large institutions have $18.6M invested in Precision BioSciences in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
8% more funds holding
Funds holding: 48 → 52 (+4)
3.89% more ownership
Funds ownership: 36.13% → 40.02% (+3.9%)
3% more capital invested
Capital invested by funds: $18.1M → $18.6M (+$575K)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$5.24M |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.33M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$613K |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$499K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$905K |
| 2 |
Millennium Management
New York
|
-$313K |
| 3 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$204K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$112K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$97.1K |
DTIL Hedge Fund Activity: Q2 2025 in Review
52 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2025, worth a combined $18.6M — up 3.2% from $18.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new DTIL positions and 7 closed out — a net gain of 4 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was Bleichroeder LP, adding an estimated $5.24M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $905K sold.
- 52 institutional investors held Precision BioSciences (DTIL) as of Q2 2025, up from 48 in Q1 2025.
- Funds reported $18.6M of Precision BioSciences stock for Q2 2025, up 3.2% quarter-over-quarter.
- 11 funds opened new Precision BioSciences positions in Q2 2025 and 7 closed out, a net change of +4 holders.
- The largest Precision BioSciences buyer in Q2 2025 was Bleichroeder LP, an estimated $5.24M added.
- The largest Precision BioSciences seller in Q2 2025 was Balyasny Asset Management, an estimated $905K sold.
Based on aggregated 13F filings for Q2 2025.